Issue |
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
|
|
---|---|---|
Article Number | 01004 | |
Number of page(s) | 4 | |
Section | Genetic Engineering and Biotechnology Innovation | |
DOI | https://doi.org/10.1051/bioconf/202411101004 | |
Published online | 31 May 2024 |
p53 contributes to the chemotherapeutic drug doxorubicininduced cell death in colorectal cancer cell line HCT116
The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong, China
e-mail: Dengrui2020@outlook.com
Doxorubicin is a commonly used chemotherapy drug for cancer treatment, but its effectiveness varies across different cancer types. p53 is a key factor involved in cell death induced by therapeutic agents. It can be upregulated by Doxorubicin and have a function of apoptosis. To have a further study of the mechanism between p53 and Doxorubicin, we investigated whether p53 play a role in the doxorubicininduced cell death in the colorectal cancer line HCT116. Our finding revealed that p53 was upregulated in HCT116 cells when treated with doxorubicin, and knockdown of p53 decreased the sensitivity of HCT116 cells to doxorubicin. These results suggest that p53 plays an important role in doxorubicin-induced cell death in HCT116 cells, which could contribute to more effective treatment approaches.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.